Search results
Results From The WOW.Com Content Network
These two iconic pharmaceutical firms have good company as virtually the entire pharmaceutical industry outside of the weight drug titans, GLP-1 companies, Eli Lilly and Novo Nordisk, are trading ...
Pharmaceutical companies have filed more than a half-dozen lawsuits in various districts around the country, in what some analysts say is an attempt to fast-track the issue to the US Supreme Court ...
Even with that growth, the stock still trades at a fairly modest valuation. Its stock price is up 5.3% this year, compared with 16% growth for the S&P 500. Why isn't Merck's stock doing better in ...
Founded in 1958, PhRMA lobbies on behalf of pharmaceutical companies. [ 2 ] [ 3 ] PhRMA is headquartered in Washington, D.C. [ 1 ] The organization has lobbied fiercely against allowing Medicare to negotiate drug prices for Medicare recipients, [ 4 ] and filed lawsuits against the drug price provisions in the Inflation Reduction Act . [ 5 ]
Commenting on the move, Stephen Ubl's PhRMA pharmaceutical industry lobbying group called price negotiations "dangerous for millions of Americans who rely on innovative treatments." But what ...
The collapse of the deal is the latest example of how the pharmaceutical industry is battling the US government on a number of fronts, including the White House's move to license drugs that were ...
A bottom-line whiff and reduced guidance made the company an outlier for the wrong reasons on Hump Day. Why Ascendis Pharma Stock Tumbled by 11% Today Skip to main content
While most pharmas are up this year, many even handily beating the S&P 500, Bristol-Myers Squibb (NYS: BMY) has struggled. Bristol-Myers Squibb data by YCharts. Blame it on Plavix Not directly ...